Literature DB >> 28668174

Paraneoplastic thrombocytosis is associated with increased mortality and increased rate of lymph node metastasis in oesophageal adenocarcinoma.

Agoston T Agoston1, Amitabh Srivastava2, Yifan Zheng2, Raphael Bueno2, Robert D Odze2, Zoltan Szallasi3.   

Abstract

Paraneoplastic thrombocytosis has been associated with adverse outcomes in several cancers, but has not been described in oesophageal adenocarcinoma. The aim of our study was to examine the prognostic value of platelet counts in patients with oesophageal adenocarcinoma. A cohort of 584 patients who underwent oesophagectomy for oesophageal adenocarcinoma was identified. Platelet counts, history of neoadjuvant chemoradiation, and clinicopathological factors such as T and N stage, and overall survival were recorded. Patients with elevated platelet count (>450,000/μL) had a higher mortality rate than patients with normal platelet count (150,000-450,000/μL) (hazard ratio = 2.60, p = 0.0013). This effect was seen in patients with and without neoadjuvant chemoradiation therapy. Paraneoplastic thrombocytosis was also associated with increased likelihood of lymph node metastasis compared to normal platelet count (69% versus 31%, p < 0.01). Paraneoplastic thrombocytosis is associated with increased rate of lymph node metastasis and mortality in oesophageal adenocarcinoma. Further studies are needed to examine the mechanisms behind this phenomenon.
Copyright © 2017 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Paraneoplastic thrombocytosis; lymph node metastasis; mortality; oesophageal adenocarcinoma; platelet count

Mesh:

Year:  2017        PMID: 28668174     DOI: 10.1016/j.pathol.2017.04.001

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  4 in total

1.  Platelet Count is Associated with the Rate of Lymph Node Metastasis in Lung Adenocarcinoma.

Authors:  Cheng-Hao Qu; Tong Li; Zhan-Peng Tang; Xi-Rui Zhu; Jing-Yi Han; Hui Tian
Journal:  Cancer Manag Res       Date:  2020-10-07       Impact factor: 3.989

2.  Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis.

Authors:  Liubing Hu; Jiyue Liu; Hideaki Shimada; Masaaki Ito; Kazuo Sugimoto; Takaki Hiwasa; Qinghua Zhou; Jianshuang Li; Si Shen; Hao Wang
Journal:  Front Oncol       Date:  2022-05-17       Impact factor: 5.738

Review 3.  The "Janus Face" of Platelets in Cancer.

Authors:  Maria Valeria Catani; Isabella Savini; Valentina Tullio; Valeria Gasperi
Journal:  Int J Mol Sci       Date:  2020-01-25       Impact factor: 5.923

4.  Interleukin-6 and thrombopoietin concentrations in dogs with carcinoma with and without thrombocytosis.

Authors:  Adrienne Cheney; Andrew D Woolcock; Abhijit Mukhopadhyay; Deborah Knapp; George E Moore
Journal:  J Vet Intern Med       Date:  2021-12-08       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.